Breathing pure oxygen during an MRI may reveal whether liver cancer treatment is working
NCT ID NCT07617038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special type of MRI, called dynamic oxygen-enhanced MRI, can predict how liver cancer responds to a treatment called transarterial chemoembolization (TACE). The MRI measures oxygen levels in tumors before and after treatment. About 60 adults with liver cancer will undergo the scan. If the technique works, it could help doctors quickly see if the treatment is effective and adjust care accordingly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRI contrast-enhancing agents
What this could lead to
If successful, this MRI technique could help doctors quickly tell if a liver cancer treatment is working, allowing them to adjust therapy sooner.
What could go wrong
This is a small, early-stage imaging study, not a treatment trial. The MRI method may not reliably predict response in all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRCHUM
Montreal, Quebec, H2X0A9, Canada